CureApp

CureApp is a digital therapeutics company that specializes in clinically-validated healthcare solutions for a range of diseases.

CureApp is active in the iot device & ict space based in Tokyo, Japan.

Profile

CureApp is a software as a medical device developer focusing on evidence-based digital therapeutics. Our mobile applications provide clinically proven therapeutic effects to solve some of the most challenging lifestyle diseases through cloud-based Cognitive Behavioral Therapy models, each personalized based on a patient’s characteristics and daily habits. Pipelines: - Tobacco cessation (completed phase III RCT): This module combines a Bluetooth carbon monoxide monitor with an app to assist users in smoking cessation. We are awaiting regulatory approval in Japan and the US. It is already in use in Japan. - NASH (Nonalcoholic steatohepatitis) (undergoing phase II) and Hypertension (undergoing phase III): These modules guide users in instituting lifestyle changes to affect positive changes in these diseases. With the power of software, we are developing easy-to-access treatment options for patients, improved clinical outcomes, and increased cost-savings to insurance providers.

Its activity falls under iot device & ict; the profile below is assembled from public directory data.

Its base of operations is Tokyo, Japan.

Its current recorded stage is J-Startup selected company.

Website: cureapp.co.jp